$PMCB Pharmacyte Biotech Cell-in-a-Box® cell encapsulation technology as THE future of diabetes treatment and suggest the Company is a prime buy out candidate from a major such as Bayer and other Big BioTech who may be closely watching PMCB.
$PMCB Watch The Cell-in-a-Box® technology, developed by Austrianova, is a means to protect, isolate, store and transport living cells to treat sickness people
News 
Market Data 
Discover 
